Eliquis (Apixaban) is a Factor Xa inhibitor, a newer class of anticoagulants that works by blocking a protein involved in blood clotting. The FDA approved Eliquis in 2012 to help reduce the risk of stroke and emobolism in patients diagnosed with non-valvular atrial fibrillation and to prevent deep vein thrombosis after knee or hip replacement surgery. The blood thinner, manufactured by Pfizer and Bristol-Myers Squibb, was promoted as a more convenient and effective drug than Warfarin (Coumadin) and quickly gained blockbuster status.

Blood Thinner Eliquis and Uncontrollable Bleeding

While Eliquis has minimal contraindications with foods or other prescription medications, the drug can cause uncontrolled bleeding, leading to potentially life-threatening complications. This adverse side effect has generated significant concern in the medical community while spawning a wave of litigation.  Blood thinner lawsuits concerning Eliquis allege a number of grave injuries — some fatal — including:

  • Cerebral hemorrhages
  • Gastrointestinal bleeding
  • Uncontrolled internal hemorrhages
  • Hemorrhagic stroke
  • Cardiac bleeds
  • Rectal bleeding

Plaintiffs are suing Pfizer and Bristol-Myers Squibb after suffering uncontrollable bleeding events brought on by Eliquis that required hospitalization, costly medical treatments, and in some cases, blood transfusions.
Plaintiffs contend that Eliquis lacked adequate warnings about risk for internal bleeding. The lawsuits also argue that the defendants failed to identify an antidote to bleeding events before introducing the medication.
According to court documents, Pfizer and Bristol Meyers Squibb:

  • Negligently promoted Eliquis without thorough pre-market testing
  • Concealed dangerous side effects from the public
  • Failed to investigate reports of uncontrolled bleeding from Eliquis
  • Negligently failed to recommend routine blood monitoring while taking Eliquis

Litigation also contends that Eliquis drug manufacturers not only concealed information about bleeding risks but provided false information to the FDA about the safety of Apixaban.

Lawsuits filed against Eliquis manufacturer

Legal actions against Eliquis manufacturers allege that the defendants:

  • Negligently promoted Eliquis without thorough pre-market testing
  • Failed to investigate reports of uncontrolled bleeding from Eliquis
  • Negligently failed to recommend routine blood monitoring while taking Eliquis
  • Provided misleading claims to the FDA about the safety of Apixaban
  • Failed to review questionable results from its ARISTOTLE clinical trials
  • Engaged in a willful indifference to health, safety and welfare of patients


At present there are dozens of Eliquis complaints pending in various courts across the country. An Eliquis multidistrict litigation (MDL No. 2754) was established in the U.S. District Court for the Southern District of New York in 2017. This year, Judge Denise L. Cote dismissed 54 of the federal MDL cases after rejecting the jurisdictional arguments. The future of MDL 2754 remains uncertain, but there are a substantial number of Eliquis claims filed in the state court system as well.

Eliquis Plaintiff’s Can Receive Compensation

By filing a blood thinner lawsuit, plaintiffs may seek compensation for a variety of losses stemming from their Eliquis injuries, including:

  • Lost income
  • Medical expenses – past and future
  • Pain and suffering
  • Emotional distress
  • Burial and funeral expenses in cases of wrongful death


Contact a Eliquis lawyer

Showard Law Firm is investigating claims involving Eliquis bleeding injuries and wrongful death. Pharmaceutical makers have a duty to ensure the products they manufacture and distribute are safe and effective for their intended purpose. If there are risks of adverse side effects with their medication, they are obligated to provide sufficient warning or face legal repercussions.

As your local law firm, we meet with every plaintiff, offering compassion and expertise. Call today to set up a free consultation with a member of our team.

Additional Eliquis Resources:

  1. Prescrire International, Bleeding with Dabigatran, Rivaroxaban, Apixaban. No antidote, and little clinical experience https://www.ncbi.nlm.nih.gov/pubmed/23866358
  2. HealthDay, Anti-Clotting Drug May Cause Severe Bleeding With No Benefit https://consumer.healthday.com/cardiovascular-health-information-20/heart-stroke-related-stroke-353/anti-clotting-drug-may-cause-severe-bleeding-with-no-benefit-655145.html
  3. Bristol Meyers Squibb, Eliquis Package Insert https://packageinserts.bms.com/pi/pi_eliquis.pdf

Schedule your FREE consultation

Contact us today to schedule your free consultation with one of our attorneys

Please call (520)622-3344 or toll free (866)307-2147

Se Habla Español